LU75648A1 - - Google Patents
Info
- Publication number
- LU75648A1 LU75648A1 LU75648A LU75648A LU75648A1 LU 75648 A1 LU75648 A1 LU 75648A1 LU 75648 A LU75648 A LU 75648A LU 75648 A LU75648 A LU 75648A LU 75648 A1 LU75648 A1 LU 75648A1
- Authority
- LU
- Luxembourg
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL7510104A NL7510104A (nl) | 1975-08-27 | 1975-08-27 | Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU75648A1 true LU75648A1 (en:Method) | 1977-03-31 |
Family
ID=19824362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU75648A LU75648A1 (en:Method) | 1975-08-27 | 1976-08-24 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4083973A (en:Method) |
| JP (1) | JPS5231063A (en:Method) |
| AU (1) | AU508727B2 (en:Method) |
| BE (1) | BE845613A (en:Method) |
| CA (1) | CA1092025A (en:Method) |
| DE (1) | DE2638507A1 (en:Method) |
| FR (1) | FR2321892A1 (en:Method) |
| GB (1) | GB1563302A (en:Method) |
| GR (1) | GR70296B (en:Method) |
| HU (1) | HU176743B (en:Method) |
| IE (1) | IE44533B1 (en:Method) |
| IL (1) | IL50274A (en:Method) |
| LU (1) | LU75648A1 (en:Method) |
| NL (1) | NL7510104A (en:Method) |
| NZ (1) | NZ181865A (en:Method) |
| PH (1) | PH12363A (en:Method) |
| ZA (1) | ZA764868B (en:Method) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT358530B (de) * | 1978-04-25 | 1980-09-10 | Plc Pharma Licences | Stabilisierungsverfahren |
| FR2427100A1 (fr) * | 1978-06-02 | 1979-12-28 | Kali Chemie Pharma Gmbh | Composition pharmaceutique a propriete de resorption amelioree et procede pour sa fabrication |
| EP0177342A3 (en) * | 1984-10-04 | 1987-12-02 | Genentech, Inc. | Oral formulation of therapeutic proteins |
| US5140021A (en) * | 1986-04-16 | 1992-08-18 | Genesis Systems Corporation | Method and dosage form for treatment of premenstrual syndrome |
| US5208032A (en) * | 1988-07-15 | 1993-05-04 | Rutgers, The State University Of New Jersey | Increasing the growth of turkeys using implant of 19-nortestosterone |
| WO1995025504A1 (en) * | 1994-03-18 | 1995-09-28 | Pharmavene, Inc. | Emulsified drug delivery systems |
| US5824638A (en) * | 1995-05-22 | 1998-10-20 | Shire Laboratories, Inc. | Oral insulin delivery |
| US6011027A (en) * | 1999-02-18 | 2000-01-04 | Lpj Research, Inc. | Use of 19-nor-4-androstenediol to increase 19-nortestosterone levels in humans |
| US6652880B1 (en) | 1999-04-01 | 2003-11-25 | R.P. Scherer Technologies, Inc. | Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants |
| US6503894B1 (en) * | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| US20040002482A1 (en) * | 2000-08-30 | 2004-01-01 | Dudley Robert E. | Androgen pharmaceutical composition and method for treating depression |
| US20040092494A9 (en) * | 2000-08-30 | 2004-05-13 | Dudley Robert E. | Method of increasing testosterone and related steroid concentrations in women |
| AU2003231126A1 (en) | 2002-04-25 | 2003-11-10 | Banner Pharmacaps, Inc. | Chewable soft capsule |
| GB0304927D0 (en) * | 2003-03-04 | 2003-04-09 | Resolution Chemicals Ltd | Process for the production of tibolone |
| US8784869B2 (en) | 2003-11-11 | 2014-07-22 | Mattern Pharma Ag | Controlled release delivery system for nasal applications and methods of treatment |
| ES2258694T3 (es) * | 2003-11-11 | 2006-09-01 | Mattern, Udo | Sistema de administracion de liberacion controlada de hormonas sexuales para aplicaciones nasales. |
| CN1257711C (zh) * | 2003-12-05 | 2006-05-31 | 石药集团中奇制药技术（石家庄）有限公司 | 丁苯酞软胶囊及其制备工艺 |
| US20060140820A1 (en) | 2004-12-28 | 2006-06-29 | Udo Mattern | Use of a container of an inorganic additive containing plastic material |
| US20070088012A1 (en) * | 2005-04-08 | 2007-04-19 | Woun Seo | Method of treating or preventing type-2 diabetes |
| FI3456329T3 (fi) | 2005-10-12 | 2025-02-27 | Besins Healthcare Lu Sarl | Parannettu testosteronigeeli ja käyttömenetelmä |
| RU2480208C2 (ru) | 2006-10-04 | 2013-04-27 | М Унд П Патент Акциенгезелльшафт | Система доставки с контролируемым высвобождением для назального применения нейротрансмиттеров |
| US20130040923A1 (en) | 2011-05-13 | 2013-02-14 | Trimel Pharmaceuticals Corporation | Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
| US9757388B2 (en) | 2011-05-13 | 2017-09-12 | Acerus Pharmaceuticals Srl | Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels |
| US20130045958A1 (en) | 2011-05-13 | 2013-02-21 | Trimel Pharmaceuticals Corporation | Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
| US11744838B2 (en) | 2013-03-15 | 2023-09-05 | Acerus Biopharma Inc. | Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event |
| RU2708238C2 (ru) | 2014-06-17 | 2019-12-05 | Мерк Шарп и Доум Б.В. | Стабильные составы тестостерона ундеканоата |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2998423A (en) * | 1958-02-25 | 1961-08-29 | Organon | Esters of 19-nortestosterone |
| US3016388A (en) * | 1959-06-30 | 1962-01-09 | Organon | New esters of 19-nor-testosterone |
| US3400197A (en) * | 1965-01-26 | 1968-09-03 | Robins Co Inc A H | Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules |
| NL189235C (nl) * | 1974-02-28 | 1993-02-16 | Akzo Nv | Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking. |
-
1975
- 1975-08-27 NL NL7510104A patent/NL7510104A/xx not_active Application Discontinuation
-
1976
- 1976-08-11 IE IE1778/76A patent/IE44533B1/en unknown
- 1976-08-12 ZA ZA764868A patent/ZA764868B/xx unknown
- 1976-08-16 US US05/714,454 patent/US4083973A/en not_active Expired - Lifetime
- 1976-08-16 IL IL50274A patent/IL50274A/xx unknown
- 1976-08-17 GB GB34253/76A patent/GB1563302A/en not_active Expired
- 1976-08-19 AU AU16980/76A patent/AU508727B2/en not_active Expired
- 1976-08-24 HU HU76AO441A patent/HU176743B/hu unknown
- 1976-08-24 JP JP51101474A patent/JPS5231063A/ja active Pending
- 1976-08-24 LU LU75648A patent/LU75648A1/xx unknown
- 1976-08-25 GR GR51544A patent/GR70296B/el unknown
- 1976-08-26 NZ NZ181865A patent/NZ181865A/xx unknown
- 1976-08-26 DE DE19762638507 patent/DE2638507A1/de not_active Withdrawn
- 1976-08-26 CA CA259,950A patent/CA1092025A/en not_active Expired
- 1976-08-26 FR FR7625795A patent/FR2321892A1/fr active Granted
- 1976-08-27 BE BE170156A patent/BE845613A/xx unknown
- 1976-08-27 PH PH7618840A patent/PH12363A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL50274A0 (en) | 1976-10-31 |
| GR70296B (en:Method) | 1982-09-06 |
| IE44533L (en) | 1977-02-27 |
| HU176743B (en) | 1981-05-28 |
| AU508727B2 (en) | 1980-04-03 |
| AU1698076A (en) | 1978-02-23 |
| FR2321892B1 (en:Method) | 1979-05-25 |
| IE44533B1 (en) | 1981-12-30 |
| IL50274A (en) | 1980-11-30 |
| DE2638507A1 (de) | 1977-03-03 |
| NL7510104A (nl) | 1977-03-01 |
| PH12363A (en) | 1979-01-29 |
| GB1563302A (en) | 1980-03-26 |
| BE845613A (fr) | 1977-02-28 |
| ZA764868B (en) | 1977-07-27 |
| FR2321892A1 (fr) | 1977-03-25 |
| JPS5231063A (en) | 1977-03-09 |
| US4083973A (en) | 1978-04-11 |
| NZ181865A (en) | 1978-12-18 |
| CA1092025A (en) | 1980-12-23 |